Cerus Corporation (CERS)
NASDAQ: CERS · Real-Time Price · USD
1.800
+0.110 (6.51%)
At close: Mar 16, 2026, 4:00 PM EDT
1.800
0.00 (0.00%)
Pre-market: Mar 17, 2026, 5:23 AM EDT
Cerus Employees
As of December 31, 2025, Cerus had 275 total employees, including 261 full-time and 14 part-time employees. The number of employees increased by 1 or 0.36% compared to the previous year.
Employees
275
Change (1Y)
1
Growth (1Y)
0.36%
Revenue / Employee
$749,575
Profits / Employee
-$56,825
Market Cap
345.91M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 275 | 1 | 0.36% | 261 | 14 |
| Dec 31, 2024 | 274 | -6 | -2.14% | 258 | 16 |
| Dec 31, 2023 | 280 | -23 | -7.59% | 268 | 12 |
| Dec 31, 2022 | 303 | 16 | 5.57% | 291 | 12 |
| Dec 31, 2021 | 287 | 21 | 7.89% | 274 | 13 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Varex Imaging | 2,400 |
| Viemed Healthcare | 1,382 |
| Standard BioTools | 818 |
| OrthoPediatrics | 602 |
| Pacific Biosciences of California | 485 |
| RxSight | 461 |
| Delcath Systems | 156 |
| Senseonics Holdings | 130 |
CERS News
- 13 hours ago - Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer - Business Wire
- 11 days ago - Cerus's Record 2025 Sets It Up For Another Leg Higher - Seeking Alpha
- 14 days ago - Cerus Corporation (CERS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results - Business Wire
- 24 days ago - Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference - Business Wire
- 27 days ago - Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026 - Business Wire
- 7 weeks ago - DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus' INTERCEPT™ Blood System in Routine Clinical Practice - Business Wire
- 2 months ago - Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook - Business Wire